HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 703-708

  Itoh, Motohiro ^a   Watanabe, Masato ^a   Yamada, Yasuaki ^b   Furukawa, Keiko ^c   Taniguchi, Masanori ^a   Hata, Tomoko ^b   Schmitt, Michael ^d   Ikeda, Hiroaki ^a   Yamaguchi, Motoko ^a   Ohno, Toshiyuki ^a   Nakashima, Kunio ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Adult T cell leukemia; Autoantigen; HTLV I; HUB1

Indexed keywords

AUTOANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN G;

ADULT; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; BLOOD; GENETICS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; T CELL LEUKEMIA;

ADULT; AMINO ACID SEQUENCE; ANTIBODY FORMATION; AUTOANTIGENS; BASE SEQUENCE; DNA, COMPLEMENTARY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, T-CELL; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ALIGNMENT;

EID: 0033113956     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.703     Document Type: Article

References (42)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S and Miyoshi I: Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78: 6476-6480, 1981.
2. Yoshida M, Miyoshi I and Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035, 1982.
3. Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F and Takatsuki K: The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 63: 1235-1240, 1984.
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M and Tara M: HTLV-1 associated myelopathy: a new clinical entity. Lancet i: 1031-1032, 1986.
5. Gessain A, Barin F, Vernant JC, Gout O, Maurus L, Calender A and De Thé G: Antibodies to human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet ii: 407-410, 1985.
6. Nishioka K, Sumida T and Hasunuma T: Human T lymphotropic virus type I in arthropathy and autoimmune disorders. Arthritis Rheum 39: 1410-1418, 1996.
7. Seiki M, Hikikoshi A, Taniguchi T and Yoshida M: Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family. Science 28: 1532-1534, 1985.
8. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F and Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229: 675-679, 1985.
9. Sodroski J, Rosen C, Goh WC and Haseltine W: A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science 228: 1430-1434, 1985.
10. Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K and Hinuma Y: Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J 6: 389-395, 1987.
11. Inoue J, Seiki M, Taniguchi T, Tsuru S and Yoshida M: Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 5: 2883-2888, 1986.
12. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F and Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promotor expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 84: 5389-5393, 1987.
13. Fujii M, Sassone-Corsi P and Verma IM: c-fos promoter transactivation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 85: 8526-8530, 1988.
14. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N and Yoshida M: Transcriptional activator Tax of HTLV-1 binds to the NF-κ precursor p105. Oncogene 7: 1737-1742, 1992.
15. Wagner S and Green MR: HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262: 395-399, 1993.
16. Fujii M, Tsuchiya H, Chuhjo T, Akizawa T and Seiki M: Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev 6: 2066-2076, 1992.
17. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G and Jay G: The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237: 1324-1329, 1987.
18. Grassmann R, Dengler C, Müller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar MC, Sodroski JG and Haseltine WA: Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpes virus saimiri vector. Proc Natl Acad Sci USA 86: 3351-3355, 1989.
19. Pozzatti R, Vogel J and Jay G: The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 10: 413-417, 1990.
20. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M and Hatanaka M: Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87: 1071-1075, 1990.
21. Fujita M and Shiku H: Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. Oncogene 11: 15-20, 1995.
22. Hino S, Sugiyama H, Doi H, Ishimaru T, Tamabc T, Tsuji Y and Miyamoto T: Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet ii: 158-159, 1987.
23. tax gene product of human T-lymphotropic virus type 1 (HTLV-1) under various conditions of HTLV-1 infection. Jpn J Cancer Res 80: 1066-1071, 1989.
24. Sahin U, Türcci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995.
25. Türeci Ö, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG and Pfreundschuh M: The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56: 4766-4772, 1996.
26. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918, 1997.
27. Türeci Ö, Schmitt H, Fadle N, Pfreundschuh M and Sahin U: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272: 6416-6422, 1997.
28. Güre AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ and Chen YT: Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 58: 1034-1041, 1998.
29. Old LJ and Chen YT: New paths in human cancer serology. J Exp Med 187: 1163-1167, 1998.
30. Chen YT, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A and Old L: Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919-6923, 1998.
31. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci Ö, Sahin U, Pfreundschuh M and Old LJ: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652-658, 1998.
32. Okumura K, Sakaguchi G, Naito K, Tamura T and Igarashi H: HUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression. Nucleic Acids Res 25: 5025-5032, 1997.
33. Hata T, Fujimoto T, Tsushima H, Murata K, Tsukasaki K, Aotogami S, Sohda H, Honda S, Mine M, Yamada Y, Ikeda S, Kamihira S and Tomonaga M: Multiclonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia. Leukemia (In press).
34. Gubler U and Hoffman BJ: A simple and very efficient method for generating cDNA libraries. Gene 25: 263-269, 1983.
35. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
36. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
37. Goppelt A, Stelzer G, Lottspeich F and Meisterernst M: A mechanism for repression of class II gene transcription through specific binding of NC2 to TBP-promoter complexes via heterodimeric histone fold domains. EMBO J 15: 3105-3116, 1996.
38. Coulter-Karis DE and Hershfield MS: Sequence of full length cDNA for human S-adenosylhomocysteine hydrolase. Ann Hum Genet 53: 169-175, 1989.
39. Shiba K, Ripmaster T, Suzuki N, Nichols R, Plotz P, Noda T and Schimmel P: Human alanyl-tRNA synthetase: conservation in evolution of catalytic core and microhelix recognition. Biochemistry 34: 10340-10349, 1995.
40. Jansen E, Meulemans SMP, Orlans ICR and van de Ven WJM: The NNP-1 gene (D21S2056E), which encodes a novel nuclear protein, maps in close proximity to the cystatin B gene within the EPM1 and APECED critical region on 21q22.3. Genomics 42: 336-341, 1997.
41. Bement WM, Hasson T, Wirth JA and Cheney RE: Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types. Proc Natl Acad Sci USA 91: 6549-6553, 1994.
42. Ishikawa K, Nagase T, Suyama M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O: Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res 30: 169-176, 1998.